Back to
CAPTRUST FINANCIAL ADVISORS
SCNI1 quarters
Position history for
CAPTRUST FINANCIAL ADVISORS's holdings in SCINAI IMMUNOTHERAPEUTICS LT
CAPTRUST FINANCIAL ADVISORS holds 12,035 shares of SCNI (SCINAI IMMUNOTHERAPEUTICS LT), worth $3,040 as of 2026-Q2. This is a new position.
Current Value
$3,040
Current Shares
12,035
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of SCNI: UBS Group AG, CITADEL ADVISORS LLC